Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct;28(5):373-8.
doi: 10.3341/kjo.2014.28.5.373. Epub 2014 Sep 18.

Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy

Yaghoobi Gholamhossein  1 , Heydari Behrouz  2 , Zarban Asghar  2
Affiliations

Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy

Yaghoobi Gholamhossein et al. Korean J Ophthalmol. 2014 Oct.

Abstract

Purpose: The purpose of this study was to evaluate whether any stage of diabetic retinopathy (DR) is associated with levels of plasma erythropoietin and other plasma parameters.

Methods: It was examined a representative sample of 180 type 2 diabetes patients aged 40 to 79 years. Ophthalmic examination including a funduscopic examination, performed by an experienced ophthalmologist and the retinal finding were classified according to the grading system for diabetic retinopathy of ETDRS (Early Treatment Diabetic Retinopathy Study). It was measured the levels of plasma erythropoietin, cholesterol, triglyceride, apolipoproteins A and B, C-reactive protein, fasting blood glucose and hemoglobin A1C (HbA1C) in 88 DR patients and 92 controls without DR. Risk factors correlated with DR were compared between groups.

Results: The study group of 180 patients included 72 males and 108 females. The mean age of the patients with and without DR was 57.36 ± 8.87 years and 55.33 ± 8.28 years, respectively. Of the 88 patients with DR, only 9 (10%) had proliferative DR and the rest suffered from non-proliferative DR. The mean plasma levels of erythropoietin in proliferative DR group showed a significant difference in comparison to other groups. The mean plasma levels of cholesterol, triglyceride, apolipoproteins A and B, C-reactive protein, and fasting blood glucose were not significantly different in the three groups except for HbA1C. The absolute relative risk (ARR) also showed that erythropoietin was an increasing risk for proliferative DR (ARR, 1.17; 95% confidence interval, 1.060 to 1.420; odds ratio,1.060).

Conclusions: Of the factors studied, erythropoietin level showed significant increase in proliferative DR group. The stepwise raised in mean plasma erythropoietin level which demonstrates significant correlation with proliferative DR versus remaining two groups, will be an indication of its role in proliferative DR.

Keywords: Diabetic retinopathy; Risk factors; Type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

    1. Riaz S. Diabetes mellitus. Sci Res Essay. 2009;4:367–373.
    1. Chatziralli IP, Sergentanis TN, Keryttopoulos P, et al. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes. 2010;3:153. - PMC - PubMed
    1. Mallika PS, Lee PY, Cheah WL, et al. Risk factors for diabetic retinopathy in diabetics screened using fundus photography at a primary health care setting in East Malaysia. Malays Fam Physician. 2011;6:60–65. - PMC - PubMed
    1. Hadhoud KM, El Hefni AM, Salem IM, et al. Monocyte chemotactic protein-1, nitrite and C-reactive protein in diabetic retinopath. J Am Sci. 2012;8:109–118.
    1. Van Geest RJ, Lesnik-Oberstein SY, Tan HS, et al. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol. 2012;96:587–590. - PMC - PubMed